These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6726784)

  • 1. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
    Reid JH; Patrick S
    J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
    Connolly JC; McLean C; Tabaqchali S
    J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Bacteroides asaccharolyticus cells and B. fragilis surface components on serum opsonisation and phagocytosis.
    Jones GR; Gemmell CG
    J Med Microbiol; 1986 Nov; 22(3):225-9. PubMed ID: 3534273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro.
    Patrick S; Reid JH; Larkin MJ
    J Med Microbiol; 1984 Jun; 17(3):237-46. PubMed ID: 6726783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
    Beena VK; Kumari N; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing.
    Allen PM; Fisher D; Saunders JR; Hart CA
    J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteraemia and seeding of capsulate Bacteroides spp. and anaerobic cocci.
    Brook I
    J Med Microbiol; 1987 Feb; 23(1):61-7. PubMed ID: 3820272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
    Wade BH; Kasper DL; Mandell GL
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial killing in vitro by abscess-derived neutrophils.
    Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
    J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1985 Jan; 38(1):86-91. PubMed ID: 3881478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
    Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
    Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of capsulate and non-capsulate Bacteroides fragilis on a discontinuous density gradient.
    Patrick S; Reid JH
    J Med Microbiol; 1983 May; 16(2):239-41. PubMed ID: 6842574
    [No Abstract]   [Full Text] [Related]  

  • 16. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis and killing of bacteria in aerobic and anaerobic conditions.
    Ingham HR; Sisson PR; Middleton RL; Narang HK; Codd AA; Selkon JB
    J Med Microbiol; 1981 Nov; 14(4):391-9. PubMed ID: 6796693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reactions to Bacteroides fragilis populations with three different types of capsule in a model of infection.
    Patrick S; Lutton DA; Crockard AD
    Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():1969-1976. PubMed ID: 7551059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
    Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interaction of Bacteroides fragilis with polymorphonuclear leukocytes and serum factors.
    Casciato DA; Rosenblatt JE; Goldberg LS; Bluestone R
    Infect Immun; 1975 Feb; 11(2):337-42. PubMed ID: 1089602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.